Piper Jaffray Expands Medical Technology Investment Research Team
May 05 2008 - 3:50PM
Business Wire
Piper Jaffray announced it has expanded its investment research
medical technology team with the addition of Tim Lee as a senior
research analyst. He will be based in the firm�s San Francisco
office and provide coverage of companies in the medical technology
sector, allowing the firm to build on its leading health care
research franchise. Lee joins Piper Jaffray with more than 10 years
of experience working for companies including Kaufman Brothers,
Merrill Lynch, SG Cowen and Salomon Brothers. He was previously a
managing director covering the medical technology sector at Caris
& Company. Lee earned a bachelor�s degree from the University
of the Pacific and a Master of Business Administration degree from
the Kelley School of Business from Indiana University. �We continue
to bring quality health care analysts to our investment research
team at Piper Jaffray and Tim is no exception,� says Joel Denney,
head of investment research at Piper Jaffray. �He will be a great
addition to the medical technology team as we continue to build on
our reputation as an industry leader in the health care sector.� In
working with hospitals, health care systems, physician groups and
HMOs, Piper Jaffray has built a leading position in U.S. health
care, and has also quickly built a reputation as one of the leading
investment banks in European health care. The firm has ranked as
the top IPO underwriter and M&A advisor in the health care
industry since 2005(a). In addition, Piper Jaffray provides
research coverage in the following health care sub-sectors:
biotechnology: biopharmaceuticals; biotechnology: therapeutics;
China healthcare; drug discovery; European biotechnology; European
medical technology; health care services: information technology;
life science tools; medical diagnostics; medical technology; and
specialty pharmaceuticals. (a) Source: Thomson Financial Securities
Data; Dealogic About Piper Jaffray Piper Jaffray Companies is a
leading, international middle-market investment bank and
institutional securities firm, serving the needs of middle-market
corporations, private equity groups, public entities, nonprofit
clients and institutional investors. Founded in 1895, Piper Jaffray
provides a comprehensive set of products and services, including
equity and debt capital markets products; public finance services;
mergers and acquisitions advisory services; high-yield and
structured products; institutional equity and fixed-income sales
and trading; and equity and high-yield research. With headquarters
in Minneapolis, Piper Jaffray has 25 offices across the United
States and international locations in London, Hong Kong, and
Shanghai. Piper Jaffray & Co. is the firm's principal operating
subsidiary. (NYSE: PJC) (http://www.piperjaffray.com) Since 1895.
Member SIPC and FINRA. � 2008 Piper Jaffray & Co., 800 Nicollet
Mall, Suite 800, Minneapolis, Minnesota 55402-7020
Piper Jaffray Companies (NYSE:PJC)
Historical Stock Chart
From Sep 2024 to Oct 2024
Piper Jaffray Companies (NYSE:PJC)
Historical Stock Chart
From Oct 2023 to Oct 2024
Real-Time news about Piper Jaffray Companies (New York Stock Exchange): 0 recent articles
More Piper Jaffray Companies News Articles